Myeloid-derived suppressor cell role in tumor-related inflammation
- 22 April 2008
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 267 (2) , 216-225
- https://doi.org/10.1016/j.canlet.2008.03.012
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor functionBlood, 2008
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- The Terminology Issue for Myeloid-Derived Suppressor CellsCancer Research, 2007
- Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell functionThe Journal of Experimental Medicine, 2006
- l-arginine availability regulates T-lymphocyte cell-cycle progressionBlood, 2006
- Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cellsJournal of Clinical Investigation, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Inflammation and cancerNature, 2002